Inventor
Ryan J. SCAMP
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
G01NInvestigating or analysing materials by determining their chemical or physical properties6%
PatentTitleYear
12,497,383Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases202512,448,373Azetidinyl-acetamides as CXCR7 inhibitors202512,371,433Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases202511,866,429Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases202411,713,307Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to CHEMOCENTRYX INC (5)· patent assignee history
2023–2025Based in US· patent location history
2025Patents assigned to AMGEN INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHEMOCENTRYX INC | 5 | 2023–2025 |
| AMGEN INC | 2 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2023–2025 |